TriSalus Life Sciences (TLSIW) Gross Margin (2022 - 2026)
TriSalus Life Sciences (TLSIW) reported Gross Margin of 86.18% for Q1 2026, up 249.0% on a YoY basis from 24.69% in Q1 2025, and down 0.55% quarter-over-quarter from 86.66% in Q4 2025.
TriSalus Life Sciences (TLSIW) Gross Margin (2022 - 2026) Analysis & Trends
TriSalus Life Sciences has reported Gross Margin for 5 years, with the latest figure at 86.18% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 249.0% year-over-year to 86.18%; the trailing twelve-month figure through Mar 2026 stood at 85.07% (down 53.0% YoY), and the FY2025 full-year result was 84.57%, down 148.0% from the prior year.
- Gross Margin for Q1 2026 stood at 86.18%, down from 86.66% in the prior quarter.
- The five-year high for Gross Margin was 89.83% in Q4 2023, with the low at 74.71% in Q4 2022.
- Historically, Gross Margin has averaged 84.3% across 5 years, with a median of 84.96% in 2024.
- Annual changes were most pronounced in 2023 — Gross Margin jumped 1512 bps — and 2024, when it plunged 455 bps.
- TriSalus Life Sciences' Gross Margin stood at 74.71% in 2022, then rose by 20 bps to 89.83% in 2023, then retreated by 5 bps to 85.28% in 2024, then grew by 2 bps to 86.66% in 2025, then dropped by 1 bps to 86.18% in 2026.
- The last three Gross Margin figures came in at 86.18% (Q1 2026), 86.66% (Q4 2025), and 83.52% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 78.01% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 38.53% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 62.95% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 43.89% |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | 86.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.18% |
| Dec 31, 2025 | 86.66% |
| Sep 30, 2025 | 83.52% |
| Jun 30, 2025 | 83.93% |
| Mar 31, 2025 | 83.69% |
| Dec 31, 2024 | 85.28% |
| Sep 30, 2024 | 86.34% |
| Jun 30, 2024 | 87.62% |
| Mar 31, 2024 | 84.96% |
| Dec 31, 2023 | 89.83% |
| Sep 30, 2023 | 88.66% |
| Jun 30, 2023 | 83.26% |
| Mar 31, 2023 | 77.82% |
| Dec 31, 2022 | 74.71% |
| Sep 30, 2022 | 82.13% |